What Organogenesis Holdings Inc.'s executives and directors are doing with their own shares, from SEC Form 3/4/5 filings — separating what the filings state (awards, withholding, disclosed plans) from what only the pattern of dates shows.
| 3 months | 12 months | |
|---|---|---|
| Open-market buys | 0 | 2 |
| Sells | 0 | 4 |
| Total trades | 0 | 55 |
| 3 months | 12 months | |
|---|---|---|
| Acquired | 0 | 0 |
| Disposed | 0 | 0 |
| Net activity | +0 | +0 |
Common stock only — 55 reported trades in the last 12 months are in a security these totals do not cover.
View rich charts and dive into the patterns of specific insiders — who is accumulating, who is winding down, and which sale explanations the filings actually support.
| Insider | Relation | Date | Transaction | Shares | Price | Value | Shares held |
|---|---|---|---|---|---|---|---|
| Leibowitz Arthur S | Director | Mar 09 | Open-market buy · P | +5,000 | $2.68 | +$13.4K | 291,014 |
| Driscoll Michael Joseph | Director | Mar 09 | Open-market buy · P | +10,000 | $2.67 | +$26.7K | 225,707 |
| Cavorsi Robert | Vice President, Strategy | Mar 01 | Withheld — tax / exercise cost · F | −700 | $3.21 | −$2.25K | 275,524 |
| Duraibabu Prathyusha | Director | Feb 18 | Grant / award · A | +48,828 | — | — | 247,047 |
| Korfin Michele Ilene | Director | Feb 18 | Grant / award · A | +48,828 | — | — | 239,073 |
| Quintero Gilberto | Director | Feb 18 | Grant / award · A | +48,828 | — | — | 239,073 |
| Francisco David | Chief Financial Officer | Feb 18 | Withheld — tax / exercise cost · F | −14,687 | $3.84 | −$56.4K | 731,312 |
| Francisco David | Chief Financial Officer | Feb 18 | Grant / award · A | +44,040 | — | — | 745,999 |
| Gillheeney Gary S. | President and CEO | Feb 18 | Withheld — tax / exercise cost · F | −91,311 | $3.84 | −$351K | 4,232,087 |
| Gillheeney Gary S. | President and CEO | Feb 18 | Grant / award · A | +188,856 | — | — | 4,323,398 |
| Bilbo Patrick | Chief Operating Officer | Feb 18 | Withheld — tax / exercise cost · F | −16,375 | $3.84 | −$62.9K | 1,128,312 |
| Bilbo Patrick | Chief Operating Officer | Feb 18 | Grant / award · A | +49,102 | — | — | 1,144,687 |
| Giacomin Jon L | Director | Feb 18 | Grant / award · A | +48,828 | — | — | 241,026 |
| Freedman Lori | Chief Admin. and Legal Officer | Feb 18 | Withheld — tax / exercise cost · F | −14,411 | $3.84 | −$55.3K | 1,023,643 |
| Freedman Lori | Chief Admin. and Legal Officer | Feb 18 | Grant / award · A | +43,212 | — | — | 1,038,054 |
| Leibowitz Arthur S | Director | Feb 18 | Grant / award · A | +48,828 | — | — | 286,014 |
| Montecalvo Antonio S. | Vice President, Health Policy | Feb 18 | Withheld — tax / exercise cost · F | −3,778 | $3.84 | −$14.5K | 226,238 |
| Montecalvo Antonio S. | Vice President, Health Policy | Feb 18 | Grant / award · A | +11,330 | — | — | 230,016 |
| Driscoll Michael Joseph | Director | Feb 18 | Grant / award · A | +48,828 | — | — | 215,707 |
| Cavorsi Robert | Vice President, Strategy | Feb 18 | Withheld — tax / exercise cost · F | −5,487 | $3.84 | −$21.1K | 276,224 |
Loading...
